Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.

MLA

Pinato, David J., et al. “Vaccination against SARS-CoV-2 Protects from Morbidity, Mortality and Sequelae from COVID19 in Patients with Cancer.” European Journal of Cancer (Oxford, England : 1990), vol. 171, Aug. 2022, pp. 64–74. EBSCOhost, https://doi.org/10.1016/j.ejca.2022.04.036.

APA

Pinato, D. J., Ferrante, D., Aguilar-Company, J., Bower, M., Salazar, R., Mirallas, O., Sureda, A., Bertuzzi, A., Brunet, J., Lambertini, M., Maluquer, C., Pedrazzoli, P., Biello, F., Lee, A. J. X., Sng, C. C. T., Liñan, R., Rossi, S., Carmona-García, M. C., Sharkey, R., … Cortellini, A. (2022). Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. European Journal of Cancer (Oxford, England : 1990), 171, 64–74. https://doi.org/10.1016/j.ejca.2022.04.036

Chicago

Pinato, David J, Daniela Ferrante, Juan Aguilar-Company, Mark Bower, Ramon Salazar, Oriol Mirallas, Anna Sureda, et al. 2022. “Vaccination against SARS-CoV-2 Protects from Morbidity, Mortality and Sequelae from COVID19 in Patients with Cancer.” European Journal of Cancer (Oxford, England : 1990) 171 (August): 64–74. doi:10.1016/j.ejca.2022.04.036.